OC
Oarsman Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
4,387
+45
| +1% | +$20K | 0.31% | 62 |
|
|
2025
Q1 | $2.11M | Buy |
4,342
+176
| +4% | +$85.3K | 0.38% | 56 |
|
|
2024
Q4 | $1.68M | Buy |
4,166
+43
| +1% | +$17.3K | 0.29% | 66 |
|
|
2024
Q3 | $1.92M | Sell |
4,123
-953
| -19% | -$443K | 0.35% | 58 |
|
|
2024
Q2 | $2.38M | Buy |
5,076
+146
| +3% | +$68.4K | 0.52% | 37 |
|
|
2024
Q1 | $2.06M | Sell |
4,930
-611
| -11% | -$255K | 0.49% | 42 |
|
|
2023
Q4 | $2.25M | Buy |
5,541
+648
| +13% | +$264K | 0.6% | 41 |
|
|
2023
Q3 | $1.7M | Buy |
4,893
+86
| +2% | +$29.9K | 0.71% | 35 |
|
|
2023
Q2 | $1.69M | Buy |
4,807
+852
| +22% | +$300K | 0.74% | 37 |
|
|
2023
Q1 | $1.25M | Buy |
3,955
+928
| +31% | +$292K | 0.58% | 45 |
|
|
2022
Q4 | $874K | Buy |
3,027
+865
| +40% | +$250K | 0.45% | 69 |
|
|
2022
Q3 | $626K | Buy |
+2,162
| New | +$626K | 0.34% | 81 |
|